Cargando…

Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion

SIMPLE SUMMARY: Exosomes, a class of extra cellular nano-sized vesicles (EVs), and their contents have gained attention as potential sources of information on tumor detection and regulatory drivers of tumor progression and metastasis. We report that exosomes from serum of patients with Epidermal Gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jouida, Amina, O’Callaghan, Marissa, Mc Carthy, Cormac, Fabre, Aurelie, Nadarajan, Parthiban, Keane, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367273/
https://www.ncbi.nlm.nih.gov/pubmed/35954442
http://dx.doi.org/10.3390/cancers14153776
_version_ 1784765755871461376
author Jouida, Amina
O’Callaghan, Marissa
Mc Carthy, Cormac
Fabre, Aurelie
Nadarajan, Parthiban
Keane, Michael P.
author_facet Jouida, Amina
O’Callaghan, Marissa
Mc Carthy, Cormac
Fabre, Aurelie
Nadarajan, Parthiban
Keane, Michael P.
author_sort Jouida, Amina
collection PubMed
description SIMPLE SUMMARY: Exosomes, a class of extra cellular nano-sized vesicles (EVs), and their contents have gained attention as potential sources of information on tumor detection and regulatory drivers of tumor progression and metastasis. We report that exosomes from serum of patients with Epidermal Growth Factor Receptor (EGFR) -mutated non-small cell lung cancer (NSCLC) induce invasion by promoting hybrid EMT. We depict exosomes as valuable actors of metastasis formation and establishment of pre-metastatic niche. Patients with an EGFR mutation are prone to metastatic recurrence. Exosomes should therefore be strongly considered as key players in cancer relapse but also as major actors in the establishment of the pre-metastatic niche. ABSTRACT: Exosomes, a class of extra cellular nano-sized vesicles (EVs), and their contents have gained attention as potential sources of information on tumor detection and regulatory drivers of tumor progression and metastasis. The effect of exosomes isolated from patients with an Epidermal Growth Factor Receptor (EGFR)-mutated adenocarcinoma on the promotion of epithelial–mesenchymal transition (EMT) and invasion were examined. Exosomes derived from serum of patients with EGFR-mutated non-small cell lung cancer (NSCLC) mediate the activation of the Phosphoinositide 3-kinase (PI3K)/AKT/ mammalian target of rapamycin (mTOR) pathway and induce an invasion through the up-regulation of matrix metalloproteinase-9 (MMP-9) in A549 cells. We observed a significant increase in the expression of vimentin, a mesenchymal marker, while retaining the epithelial characteristics, as evidenced by the unaltered levels of E-cadherin and Epithelial cell adhesion molecule (EPCAM). We also observed an increase of nuclear factor erythroid 2-related factor 2 (NFR2) and P-cadherin expression, markers of hybrid EMT. Exosomes derived from EGFR-mutated adenocarcinoma serum could be a potential mediator of hybrid EMT and tumor invasion. Understanding how cancerous cells communicate and interact with their environment via exosomes will improve our understanding of lung cancer progression and metastasis formation.
format Online
Article
Text
id pubmed-9367273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93672732022-08-12 Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion Jouida, Amina O’Callaghan, Marissa Mc Carthy, Cormac Fabre, Aurelie Nadarajan, Parthiban Keane, Michael P. Cancers (Basel) Article SIMPLE SUMMARY: Exosomes, a class of extra cellular nano-sized vesicles (EVs), and their contents have gained attention as potential sources of information on tumor detection and regulatory drivers of tumor progression and metastasis. We report that exosomes from serum of patients with Epidermal Growth Factor Receptor (EGFR) -mutated non-small cell lung cancer (NSCLC) induce invasion by promoting hybrid EMT. We depict exosomes as valuable actors of metastasis formation and establishment of pre-metastatic niche. Patients with an EGFR mutation are prone to metastatic recurrence. Exosomes should therefore be strongly considered as key players in cancer relapse but also as major actors in the establishment of the pre-metastatic niche. ABSTRACT: Exosomes, a class of extra cellular nano-sized vesicles (EVs), and their contents have gained attention as potential sources of information on tumor detection and regulatory drivers of tumor progression and metastasis. The effect of exosomes isolated from patients with an Epidermal Growth Factor Receptor (EGFR)-mutated adenocarcinoma on the promotion of epithelial–mesenchymal transition (EMT) and invasion were examined. Exosomes derived from serum of patients with EGFR-mutated non-small cell lung cancer (NSCLC) mediate the activation of the Phosphoinositide 3-kinase (PI3K)/AKT/ mammalian target of rapamycin (mTOR) pathway and induce an invasion through the up-regulation of matrix metalloproteinase-9 (MMP-9) in A549 cells. We observed a significant increase in the expression of vimentin, a mesenchymal marker, while retaining the epithelial characteristics, as evidenced by the unaltered levels of E-cadherin and Epithelial cell adhesion molecule (EPCAM). We also observed an increase of nuclear factor erythroid 2-related factor 2 (NFR2) and P-cadherin expression, markers of hybrid EMT. Exosomes derived from EGFR-mutated adenocarcinoma serum could be a potential mediator of hybrid EMT and tumor invasion. Understanding how cancerous cells communicate and interact with their environment via exosomes will improve our understanding of lung cancer progression and metastasis formation. MDPI 2022-08-03 /pmc/articles/PMC9367273/ /pubmed/35954442 http://dx.doi.org/10.3390/cancers14153776 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jouida, Amina
O’Callaghan, Marissa
Mc Carthy, Cormac
Fabre, Aurelie
Nadarajan, Parthiban
Keane, Michael P.
Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
title Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
title_full Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
title_fullStr Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
title_full_unstemmed Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
title_short Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
title_sort exosomes from egfr-mutated adenocarcinoma induce a hybrid emt and mmp9-dependant tumor invasion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367273/
https://www.ncbi.nlm.nih.gov/pubmed/35954442
http://dx.doi.org/10.3390/cancers14153776
work_keys_str_mv AT jouidaamina exosomesfromegfrmutatedadenocarcinomainduceahybridemtandmmp9dependanttumorinvasion
AT ocallaghanmarissa exosomesfromegfrmutatedadenocarcinomainduceahybridemtandmmp9dependanttumorinvasion
AT mccarthycormac exosomesfromegfrmutatedadenocarcinomainduceahybridemtandmmp9dependanttumorinvasion
AT fabreaurelie exosomesfromegfrmutatedadenocarcinomainduceahybridemtandmmp9dependanttumorinvasion
AT nadarajanparthiban exosomesfromegfrmutatedadenocarcinomainduceahybridemtandmmp9dependanttumorinvasion
AT keanemichaelp exosomesfromegfrmutatedadenocarcinomainduceahybridemtandmmp9dependanttumorinvasion